In Chapter 2 of “Precision Minute,” Dr. Stephen V. Liu, Associate Professor of Medicine, Director of Thoracic Oncology and Director of Developmental Therapeutics at the Lombardi Comprehensive Cancer Center of Georgetown University provides an overview of what treatment plans look like if you have ROS1 non-small cell lung cancer or ALK-positive NSCLC.
Learn more about ROS1 and ALK-positive NSCLC:
- Is targeted therapy right for me with NSCLC?
- ALK-positive lung cancer: what it means and targeted treatment options
- What does a ROS1 fusion mean in non-small cell cancer?
- ALK-positive and ROS1 NSCLC: can you have both?
Watch Chapter One of “Precision Minute” here.
Neither Outcomes4Me nor any participants in or contributors to any webinar, article or content endorses or recommends any products or services. Consult your physician regarding any treatment or therapy.
Personalized support for real care decisions
Understand your diagnosis, explore clinical trials, and track symptoms--all in one place.
Get started
Compare treatments, prepare for appointments, and track side effects—all in the app
Built for your diagnosis, Outcomes4Me gives you the tools to make confident, informed decisions—right when you need them.
Continue in app
